CVS Health Co. (NYSE:CVS) Shares Sold by Ceeto Capital Group LLC

Ceeto Capital Group LLC reduced its position in shares of CVS Health Co. (NYSE:CVS) by 43.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 6,676 shares of the pharmacy operator’s stock after selling 5,083 shares during the period. Ceeto Capital Group LLC’s holdings in CVS Health were worth $300,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the company. Principal Financial Group Inc. grew its position in CVS Health by 4.8% in the third quarter. Principal Financial Group Inc. now owns 1,434,476 shares of the pharmacy operator’s stock worth $90,200,000 after acquiring an additional 66,244 shares during the period. Hall Laurie J Trustee raised its holdings in CVS Health by 25,484.4% in the 4th quarter. Hall Laurie J Trustee now owns 11,513 shares of the pharmacy operator’s stock valued at $517,000 after buying an additional 11,468 shares during the period. B&D White Capital Company LLC acquired a new position in CVS Health in the fourth quarter valued at about $417,000. Watts Gwilliam & Co. LLC increased its position in shares of CVS Health by 9.8% during the fourth quarter. Watts Gwilliam & Co. LLC now owns 7,302 shares of the pharmacy operator’s stock valued at $334,000 after acquiring an additional 650 shares during the last quarter. Finally, Seizert Capital Partners LLC increased its holdings in CVS Health by 22.8% in the 4th quarter. Seizert Capital Partners LLC now owns 569,527 shares of the pharmacy operator’s stock valued at $25,566,000 after purchasing an additional 105,708 shares during the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Stock Up 0.9 %

Shares of NYSE CVS opened at $69.56 on Friday. The firm has a market cap of $87.70 billion, a P/E ratio of 19.01, a price-to-earnings-growth ratio of 0.98 and a beta of 0.57. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.60 and a current ratio of 0.81. CVS Health Co. has a 1 year low of $43.56 and a 1 year high of $71.66. The firm’s 50 day moving average price is $65.10 and its 200 day moving average price is $58.51.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, topping analysts’ consensus estimates of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. As a group, sell-side analysts anticipate that CVS Health Co. will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 1st. Stockholders of record on Tuesday, April 22nd will be given a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 3.82%. The ex-dividend date of this dividend is Tuesday, April 22nd. CVS Health’s payout ratio is currently 72.68%.

Analysts Set New Price Targets

CVS has been the subject of a number of research reports. StockNews.com raised CVS Health from a “sell” rating to a “hold” rating in a research note on Thursday, February 13th. Cantor Fitzgerald raised shares of CVS Health from a “neutral” rating to an “overweight” rating in a research report on Wednesday, February 12th. Argus set a $77.00 price objective on CVS Health in a research note on Tuesday, February 18th. Mizuho boosted their target price on CVS Health from $70.00 to $76.00 and gave the stock an “outperform” rating in a research note on Wednesday. Finally, Leerink Partners upgraded CVS Health from a “market perform” rating to an “outperform” rating and lifted their price objective for the company from $55.00 to $75.00 in a research note on Thursday, February 13th. Four equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, CVS Health currently has a consensus rating of “Moderate Buy” and an average target price of $71.28.

Insider Activity at CVS Health

In other news, SVP James David Clark sold 7,513 shares of the company’s stock in a transaction that occurred on Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total transaction of $498,487.55. Following the completion of the transaction, the senior vice president now directly owns 8,394 shares of the company’s stock, valued at approximately $556,941.90. This represents a 47.23 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Michael F. Mahoney acquired 30,000 shares of CVS Health stock in a transaction that occurred on Tuesday, February 18th. The stock was bought at an average cost of $66.70 per share, with a total value of $2,001,000.00. Following the acquisition, the director now directly owns 39,356 shares of the company’s stock, valued at approximately $2,625,045.20. This trade represents a 320.65 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Company insiders own 0.24% of the company’s stock.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.